LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Halozyme Therapeutics (NASDAQ: HALO)

Follow NASDAQ:HALO Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/16/2024
Buy
$19.98
10,000
$200K
183,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Buy
$16.65
5,509
$92K
179,265
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$53.74
9,923
$533K
173,833
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/16/2024
Sell
$53.26
10,000
$533K
173,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$54.25
77
$4K
173,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$19.98
4,491
$90K
36,608
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/16/2024
Sell
$19.98
10,000
$200K
26,608
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
10/15/2024
Sell
$16.65
5,509
$92K
6,352
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/09/2024
Buy
$13.87
10,000
$139K
686,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$51.85
5,981
$310K
680,763
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$53.31
1,615
$86K
679,148
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/08/2024
Sell
$53.94
9,100
$491K
677,644
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$53.91
2,404
$130K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/08/2024
Sell
$54.57
900
$49K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/08/2024
Sell
$13.87
10,000
$139K
10,000
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
10/09/2024
Sell
$13.87
10,000
$139K
0
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/26/2024
Buy
$13.87
10,000
$139K
686,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/25/2024
Sell
$56.34
10,000
$563K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/24/2024
Sell
$58.21
10,000
$582K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/26/2024
Sell
$56.10
10,000
$561K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/24/2024
Sell
$13.87
10,000
$139K
40,000
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/25/2024
Sell
$13.87
10,000
$139K
30,000
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/26/2024
Sell
$13.87
10,000
$139K
20,000
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/18/2024
Buy
$16.65
10,000
$167K
183,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/18/2024
Sell
$61.89
7,963
$493K
175,793
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/17/2024
Sell
$62.88
10,000
$629K
173,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/18/2024
Sell
$62.58
2,037
$127K
173,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/17/2024
Sell
$16.65
10,000
$167K
21,861
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
09/18/2024
Sell
$16.65
10,000
$167K
11,861
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/12/2024
Buy
$13.87
10,000
$139K
686,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/10/2024
Sell
$59.09
10,000
$591K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/11/2024
Sell
$59.09
10,000
$591K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/12/2024
Sell
$59.20
10,000
$592K
676,744
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/10/2024
Sell
$13.87
10,000
$139K
70,000
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/11/2024
Sell
$13.87
10,000
$139K
60,000
NASDAQ HALO Halozyme Therapeutics
Torley Helen / director, officer: PRESIDENT AND CEO
09/12/2024
Sell
$13.87
10,000
$139K
50,000
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/27/2024
Buy
$18.41
5,580
$103K
173,756
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/27/2024
Sell
$18.41
5,580
$103K
0
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/21/2024
Buy
$16.65
10,000
$167K
178,176
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/21/2024
Sell
$61.74
9,900
$611K
168,276
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/20/2024
Sell
$61.06
10,000
$611K
168,176
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/21/2024
Sell
$62.34
100
$6K
168,176
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/20/2024
Sell
$16.65
10,000
$167K
41,861
NASDAQ HALO Halozyme Therapeutics
LaBarre Michael J. / officer: SVP, CHIEF TECHNICAL OFFICER
08/21/2024
Sell
$16.65
10,000
$167K
31,861

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous